

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exocrine pancreas development (GO:0031017) | 8.70200088 |
| 2 | intestinal cholesterol absorption (GO:0030299) | 7.24722353 |
| 3 | protein retention in ER lumen (GO:0006621) | 6.37532948 |
| 4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.09219808 |
| 5 | digestion (GO:0007586) | 5.69110764 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.47286135 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 5.47286135 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.47286135 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.47286135 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.47286135 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 5.47286135 |
| 12 | negative regulation of cell killing (GO:0031342) | 5.22739873 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.22739873 |
| 14 | response to peptidoglycan (GO:0032494) | 5.04259263 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.91973722 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 4.48958973 |
| 17 | proline biosynthetic process (GO:0006561) | 4.43456965 |
| 18 | detection of other organism (GO:0098543) | 4.43447978 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.33017543 |
| 20 | valine metabolic process (GO:0006573) | 4.23677896 |
| 21 | detection of bacterium (GO:0016045) | 4.22618175 |
| 22 | detection of molecule of bacterial origin (GO:0032490) | 4.21633274 |
| 23 | detection of external biotic stimulus (GO:0098581) | 4.01886001 |
| 24 | negative regulation of interleukin-12 production (GO:0032695) | 3.98288740 |
| 25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.96919257 |
| 26 | Golgi transport vesicle coating (GO:0048200) | 3.83772990 |
| 27 | COPI coating of Golgi vesicle (GO:0048205) | 3.83772990 |
| 28 | cobalamin metabolic process (GO:0009235) | 3.77985978 |
| 29 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.77827417 |
| 30 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.76905647 |
| 31 | peptidyl-proline hydroxylation (GO:0019511) | 3.76820916 |
| 32 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.74817219 |
| 33 | positive regulation of nuclease activity (GO:0032075) | 3.74221826 |
| 34 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.74111569 |
| 35 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.66814042 |
| 36 | respiratory burst (GO:0045730) | 3.65828534 |
| 37 | cellular extravasation (GO:0045123) | 3.63428142 |
| 38 | response to host immune response (GO:0052572) | 3.58915104 |
| 39 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.58915104 |
| 40 | serine family amino acid biosynthetic process (GO:0009070) | 3.58566084 |
| 41 | detection of biotic stimulus (GO:0009595) | 3.54745742 |
| 42 | response to muramyl dipeptide (GO:0032495) | 3.50731879 |
| 43 | regulation of nuclease activity (GO:0032069) | 3.46912063 |
| 44 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.44972711 |
| 45 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.44972711 |
| 46 | response to host (GO:0075136) | 3.43907045 |
| 47 | response to host defenses (GO:0052200) | 3.43907045 |
| 48 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.43907045 |
| 49 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.43455522 |
| 50 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.43340203 |
| 51 | germinal center formation (GO:0002467) | 3.42300657 |
| 52 | neutrophil activation (GO:0042119) | 3.38458030 |
| 53 | viral transcription (GO:0019083) | 3.36916925 |
| 54 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.36433513 |
| 55 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.34241584 |
| 56 | cysteine metabolic process (GO:0006534) | 3.33841010 |
| 57 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.33614872 |
| 58 | regulation of gamma-delta T cell activation (GO:0046643) | 3.33482405 |
| 59 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.31966388 |
| 60 | regulation of mast cell degranulation (GO:0043304) | 3.31473425 |
| 61 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.29998563 |
| 62 | glycine metabolic process (GO:0006544) | 3.29220600 |
| 63 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.29198979 |
| 64 | translational termination (GO:0006415) | 3.28977425 |
| 65 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.28232076 |
| 66 | regulation of leukocyte degranulation (GO:0043300) | 3.27109315 |
| 67 | intestinal absorption (GO:0050892) | 3.26342056 |
| 68 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.24918300 |
| 69 | cellular response to unfolded protein (GO:0034620) | 3.24046241 |
| 70 | response to interleukin-15 (GO:0070672) | 3.22184919 |
| 71 | granulocyte activation (GO:0036230) | 3.21299381 |
| 72 | 4-hydroxyproline metabolic process (GO:0019471) | 3.21146856 |
| 73 | protein hydroxylation (GO:0018126) | 3.20212277 |
| 74 | formation of translation preinitiation complex (GO:0001731) | 3.19654868 |
| 75 | pentose-phosphate shunt (GO:0006098) | 3.17661047 |
| 76 | NIK/NF-kappaB signaling (GO:0038061) | 3.16447143 |
| 77 | macrophage activation (GO:0042116) | 3.15712877 |
| 78 | regulation of translational fidelity (GO:0006450) | 3.15505814 |
| 79 | ribosomal small subunit assembly (GO:0000028) | 3.15334424 |
| 80 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.14878251 |
| 81 | sterol catabolic process (GO:0016127) | 3.14009223 |
| 82 | cholesterol catabolic process (GO:0006707) | 3.14009223 |
| 83 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.13009431 |
| 84 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.12396097 |
| 85 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.10630203 |
| 86 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.10042876 |
| 87 | cellular response to topologically incorrect protein (GO:0035967) | 3.09449417 |
| 88 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.08708753 |
| 89 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.07386852 |
| 90 | immunoglobulin mediated immune response (GO:0016064) | 3.06920810 |
| 91 | translational elongation (GO:0006414) | 3.06222418 |
| 92 | L-serine metabolic process (GO:0006563) | 3.05566706 |
| 93 | DNA unwinding involved in DNA replication (GO:0006268) | 3.04636077 |
| 94 | protein targeting to ER (GO:0045047) | 3.03298981 |
| 95 | myeloid cell activation involved in immune response (GO:0002275) | 3.01533588 |
| 96 | proline metabolic process (GO:0006560) | 3.01305669 |
| 97 | transcytosis (GO:0045056) | 3.00233904 |
| 98 | ER-nucleus signaling pathway (GO:0006984) | 2.98161484 |
| 99 | cotranslational protein targeting to membrane (GO:0006613) | 2.96995371 |
| 100 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.95735698 |
| 101 | positive regulation of histone deacetylation (GO:0031065) | 2.92532360 |
| 102 | cellular response to type I interferon (GO:0071357) | 2.91570522 |
| 103 | type I interferon signaling pathway (GO:0060337) | 2.91570522 |
| 104 | response to type I interferon (GO:0034340) | 2.91335221 |
| 105 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.91169625 |
| 106 | neutrophil mediated immunity (GO:0002446) | 2.89817866 |
| 107 | response to endoplasmic reticulum stress (GO:0034976) | 2.89351042 |
| 108 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.89107470 |
| 109 | maternal placenta development (GO:0001893) | 2.87857523 |
| 110 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.87351538 |
| 111 | DNA deamination (GO:0045006) | 2.86434998 |
| 112 | negative regulation of phagocytosis (GO:0050765) | 2.85736980 |
| 113 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.82932669 |
| 114 | retinoic acid receptor signaling pathway (GO:0048384) | 2.82806160 |
| 115 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.82590914 |
| 116 | translesion synthesis (GO:0019985) | 2.79595135 |
| 117 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.78656288 |
| 118 | protein localization to endoplasmic reticulum (GO:0070972) | 2.77660097 |
| 119 | apoptotic process involved in morphogenesis (GO:0060561) | 2.76968360 |
| 120 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.76111228 |
| 121 | tetrahydrofolate metabolic process (GO:0046653) | 2.76023505 |
| 122 | serine family amino acid metabolic process (GO:0009069) | 2.75524204 |
| 123 | mannose metabolic process (GO:0006013) | 2.74922187 |
| 124 | translational initiation (GO:0006413) | 2.74390701 |
| 125 | positive thymic T cell selection (GO:0045059) | 2.73689369 |
| 126 | regulation of necroptotic process (GO:0060544) | 2.72815340 |
| 127 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.72705427 |
| 128 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.71935282 |
| 129 | B cell receptor signaling pathway (GO:0050853) | 2.71231176 |
| 130 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.71049926 |
| 131 | regulation of regulated secretory pathway (GO:1903305) | 2.68107228 |
| 132 | cellular response to interleukin-15 (GO:0071350) | 2.67239759 |
| 133 | negative regulation of digestive system process (GO:0060457) | 2.65642844 |
| 134 | leukotriene biosynthetic process (GO:0019370) | 2.64406451 |
| 135 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.63983087 |
| 136 | positive regulation of interferon-alpha production (GO:0032727) | 2.63585301 |
| 137 | modulation by virus of host process (GO:0019054) | 2.63494368 |
| 138 | cellular modified amino acid catabolic process (GO:0042219) | 2.63309191 |
| 139 | negative regulation of T cell mediated immunity (GO:0002710) | 2.62954752 |
| 140 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.62531106 |
| 141 | negative regulation of cell size (GO:0045792) | 2.62107561 |
| 142 | modulation by symbiont of host cellular process (GO:0044068) | 2.61267007 |
| 143 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.60102726 |
| 144 | defense response to protozoan (GO:0042832) | 2.59680020 |
| 145 | protein localization to endosome (GO:0036010) | 2.58395566 |
| 146 | NADPH regeneration (GO:0006740) | 2.57651767 |
| 147 | thymic T cell selection (GO:0045061) | 2.57636352 |
| 148 | microglial cell activation (GO:0001774) | 2.57582984 |
| 149 | response to laminar fluid shear stress (GO:0034616) | 2.56556553 |
| 150 | negative regulation of interleukin-6 production (GO:0032715) | 2.56141133 |
| 151 | negative regulation of type 2 immune response (GO:0002829) | 2.56132159 |
| 152 | one-carbon metabolic process (GO:0006730) | 2.55417552 |
| 153 | negative regulation of innate immune response (GO:0045824) | 2.54201574 |
| 154 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.53363740 |
| 155 | homocysteine metabolic process (GO:0050667) | 2.52190467 |
| 156 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.50816750 |
| 157 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.50314428 |
| 158 | viral life cycle (GO:0019058) | 2.50278876 |
| 159 | regulation of T cell tolerance induction (GO:0002664) | 2.49925596 |
| 160 | leukocyte degranulation (GO:0043299) | 2.49692895 |
| 161 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.49673478 |
| 162 | IMP biosynthetic process (GO:0006188) | 2.48679576 |
| 163 | regulation of chromatin binding (GO:0035561) | 2.48161153 |
| 164 | aspartate family amino acid catabolic process (GO:0009068) | 2.45036944 |
| 165 | B cell mediated immunity (GO:0019724) | 2.44432855 |
| 166 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.44219099 |
| 167 | response to unfolded protein (GO:0006986) | 2.43622076 |
| 168 | regulation of mast cell activation (GO:0033003) | 2.42933977 |
| 169 | protein maturation by protein folding (GO:0022417) | 2.42011054 |
| 170 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.41709252 |
| 171 | cellular protein complex disassembly (GO:0043624) | 2.38546460 |
| 172 | protein complex disassembly (GO:0043241) | 2.37674767 |
| 173 | maintenance of protein localization in organelle (GO:0072595) | 2.37615382 |
| 174 | regulation of phospholipase A2 activity (GO:0032429) | 2.36971142 |
| 175 | mitochondrial calcium ion transport (GO:0006851) | 2.35669156 |
| 176 | response to topologically incorrect protein (GO:0035966) | 2.34434340 |
| 177 | regulation of translation in response to stress (GO:0043555) | 2.33096107 |
| 178 | DNA strand elongation (GO:0022616) | 2.32596408 |
| 179 | mitotic G1/S transition checkpoint (GO:0044819) | 2.32536931 |
| 180 | branched-chain amino acid metabolic process (GO:0009081) | 2.32165035 |
| 181 | leukocyte aggregation (GO:0070486) | 2.30900827 |
| 182 | cellular hyperosmotic response (GO:0071474) | 2.29346491 |
| 183 | glycolipid catabolic process (GO:0019377) | 2.28999818 |
| 184 | tricarboxylic acid metabolic process (GO:0072350) | 2.28548107 |
| 185 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175) | 2.28325206 |
| 186 | DNA geometric change (GO:0032392) | 2.27229375 |
| 187 | DNA duplex unwinding (GO:0032508) | 2.26653491 |
| 188 | negative regulation of RNA splicing (GO:0033119) | 2.26503541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.54628913 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.26169590 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.99971509 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.51572283 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.48303575 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.41778476 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.35103477 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.35055442 |
| 9 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.27133424 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.22767353 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.09528730 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.02305998 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.91632056 |
| 14 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.87280287 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.85695291 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.85120477 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83661603 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77155426 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.72233148 |
| 20 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.72135272 |
| 21 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.72093696 |
| 22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70162475 |
| 23 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.68362140 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 1.67756075 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 1.64361723 |
| 26 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64086236 |
| 27 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.64037651 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.59722589 |
| 29 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.57449866 |
| 30 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.55449864 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.53657239 |
| 32 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.53343469 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53246203 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.52785764 |
| 35 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.49284299 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.48757093 |
| 37 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.48744969 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47422013 |
| 39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46675354 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.45582841 |
| 41 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.45513395 |
| 42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.45138231 |
| 43 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.45054963 |
| 44 | KDM2B_26808549_Chip-Seq_K562_Human | 1.44832669 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44013401 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.43611253 |
| 47 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.43208562 |
| 48 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.42898111 |
| 49 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.42477411 |
| 50 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.40973055 |
| 51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40918645 |
| 52 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.40066789 |
| 53 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.38030680 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.34975918 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34495728 |
| 56 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32050189 |
| 57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31327081 |
| 58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.29420582 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28777625 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.28337815 |
| 61 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.27907048 |
| 62 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26690005 |
| 63 | MYB_26560356_Chip-Seq_TH2_Human | 1.26285902 |
| 64 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.26181841 |
| 65 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.26167930 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.26099701 |
| 67 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25814835 |
| 68 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.25780073 |
| 69 | P68_20966046_ChIP-Seq_HELA_Human | 1.25735161 |
| 70 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.25594482 |
| 71 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.25305039 |
| 72 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.23951477 |
| 73 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.23663557 |
| 74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23399565 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.22960151 |
| 76 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.22318512 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22182308 |
| 78 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.22177250 |
| 79 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22012341 |
| 80 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21184707 |
| 81 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20298836 |
| 82 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.20249492 |
| 83 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.20165160 |
| 84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.19880204 |
| 85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19037276 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18465993 |
| 87 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.17267585 |
| 88 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.16150455 |
| 89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15713378 |
| 90 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14754177 |
| 91 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12770765 |
| 92 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.12758442 |
| 93 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.12121027 |
| 94 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11176980 |
| 95 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.10564105 |
| 96 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.10260136 |
| 97 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.10137609 |
| 98 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.09989517 |
| 99 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.09444649 |
| 100 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.08176060 |
| 101 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.08125109 |
| 102 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07498326 |
| 103 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07320203 |
| 104 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06539400 |
| 105 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06525771 |
| 106 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06299564 |
| 107 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.06297960 |
| 108 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06077277 |
| 109 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06062767 |
| 110 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05710758 |
| 111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05200302 |
| 112 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.05041262 |
| 113 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.04840269 |
| 114 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.04171881 |
| 115 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.03995282 |
| 116 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03930591 |
| 117 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03507603 |
| 118 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02702575 |
| 119 | ATF3_27146783_Chip-Seq_COLON_Human | 1.02213911 |
| 120 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01840808 |
| 121 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01236634 |
| 122 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99844302 |
| 123 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99630773 |
| 124 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.98534780 |
| 125 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.98220876 |
| 126 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.97633484 |
| 127 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97456486 |
| 128 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.97428601 |
| 129 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97048028 |
| 130 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.96807879 |
| 131 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95435537 |
| 132 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.94633594 |
| 133 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.94558228 |
| 134 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.93904319 |
| 135 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.93203300 |
| 136 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.92679300 |
| 137 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91871250 |
| 138 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91546400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005083_abnormal_biliary_tract | 5.18334046 |
| 2 | MP0001666_abnormal_nutrient_absorption | 4.65930915 |
| 3 | MP0005220_abnormal_exocrine_pancreas | 4.22026951 |
| 4 | MP0005365_abnormal_bile_salt | 3.75154432 |
| 5 | MP0003724_increased_susceptibility_to | 3.30305439 |
| 6 | MP0008260_abnormal_autophagy | 2.86091857 |
| 7 | MP0002419_abnormal_innate_immunity | 2.60466597 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.45003799 |
| 9 | MP0003868_abnormal_feces_composition | 2.34288055 |
| 10 | MP0001873_stomach_inflammation | 2.02269516 |
| 11 | MP0003693_abnormal_embryo_hatching | 2.00692614 |
| 12 | MP0009278_abnormal_bone_marrow | 1.96723588 |
| 13 | MP0009785_altered_susceptibility_to | 1.93540300 |
| 14 | MP0003763_abnormal_thymus_physiology | 1.90868086 |
| 15 | MP0005085_abnormal_gallbladder_physiolo | 1.84355182 |
| 16 | MP0001533_abnormal_skeleton_physiology | 1.79213230 |
| 17 | MP0004381_abnormal_hair_follicle | 1.77093714 |
| 18 | MP0002693_abnormal_pancreas_physiology | 1.74515848 |
| 19 | MP0002132_abnormal_respiratory_system | 1.73285988 |
| 20 | MP0005084_abnormal_gallbladder_morpholo | 1.70006950 |
| 21 | MP0002396_abnormal_hematopoietic_system | 1.68823083 |
| 22 | MP0006082_CNS_inflammation | 1.67726642 |
| 23 | MP0000685_abnormal_immune_system | 1.66709989 |
| 24 | MP0000490_abnormal_crypts_of | 1.60517693 |
| 25 | MP0003300_gastrointestinal_ulcer | 1.60115938 |
| 26 | MP0004858_abnormal_nervous_system | 1.57829942 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.55802909 |
| 28 | MP0003077_abnormal_cell_cycle | 1.53948075 |
| 29 | MP0004808_abnormal_hematopoietic_stem | 1.53188579 |
| 30 | MP0001849_ear_inflammation | 1.51718355 |
| 31 | MP0008961_abnormal_basal_metabolism | 1.51005214 |
| 32 | MP0003453_abnormal_keratinocyte_physiol | 1.49071122 |
| 33 | MP0004510_myositis | 1.47552552 |
| 34 | MP0003959_abnormal_lean_body | 1.45585829 |
| 35 | MP0004957_abnormal_blastocyst_morpholog | 1.45214358 |
| 36 | MP0001800_abnormal_humoral_immune | 1.43918231 |
| 37 | MP0003111_abnormal_nucleus_morphology | 1.41208957 |
| 38 | MP0005076_abnormal_cell_differentiation | 1.41168852 |
| 39 | MP0003828_pulmonary_edema | 1.40570996 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.39873328 |
| 41 | MP0003303_peritoneal_inflammation | 1.38319771 |
| 42 | MP0010352_gastrointestinal_tract_polyps | 1.35754947 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.35668102 |
| 44 | MP0002398_abnormal_bone_marrow | 1.35577984 |
| 45 | MP0001944_abnormal_pancreas_morphology | 1.33096944 |
| 46 | MP0003436_decreased_susceptibility_to | 1.32104949 |
| 47 | MP0010094_abnormal_chromosome_stability | 1.30061744 |
| 48 | MP0005670_abnormal_white_adipose | 1.28920523 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.28547682 |
| 50 | MP0009840_abnormal_foam_cell | 1.26923508 |
| 51 | MP0004264_abnormal_extraembryonic_tissu | 1.26838972 |
| 52 | MP0002405_respiratory_system_inflammati | 1.25763232 |
| 53 | MP0002139_abnormal_hepatobiliary_system | 1.25217188 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.24799368 |
| 55 | MP0005310_abnormal_salivary_gland | 1.23563832 |
| 56 | MP0002722_abnormal_immune_system | 1.22119696 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.21205934 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.20023935 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.20023935 |
| 60 | MP0001790_abnormal_immune_system | 1.19742579 |
| 61 | MP0005387_immune_system_phenotype | 1.19742579 |
| 62 | MP0002877_abnormal_melanocyte_morpholog | 1.15385496 |
| 63 | MP0002452_abnormal_antigen_presenting | 1.13739279 |
| 64 | MP0005451_abnormal_body_composition | 1.13462237 |
| 65 | MP0001845_abnormal_inflammatory_respons | 1.12530333 |
| 66 | MP0003866_abnormal_defecation | 1.12448529 |
| 67 | MP0003075_altered_response_to | 1.12394047 |
| 68 | MP0002723_abnormal_immune_serum | 1.11163632 |
| 69 | MP0002420_abnormal_adaptive_immunity | 1.10384651 |
| 70 | MP0005360_urolithiasis | 1.07220147 |
| 71 | MP0000716_abnormal_immune_system | 1.06744626 |
| 72 | MP0001819_abnormal_immune_cell | 1.06640653 |
| 73 | MP0003183_abnormal_peptide_metabolism | 1.05952495 |
| 74 | MP0000678_abnormal_parathyroid_gland | 1.05840659 |
| 75 | MP0002429_abnormal_blood_cell | 1.04875944 |
| 76 | MP0000598_abnormal_liver_morphology | 1.00695407 |
| 77 | MP0003091_abnormal_cell_migration | 0.99357153 |
| 78 | MP0000609_abnormal_liver_physiology | 0.99305002 |
| 79 | MP0009764_decreased_sensitivity_to | 0.99112180 |
| 80 | MP0002277_abnormal_respiratory_mucosa | 0.98933617 |
| 81 | MP0003448_altered_tumor_morphology | 0.98795560 |
| 82 | MP0010155_abnormal_intestine_physiology | 0.98675975 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 0.98305273 |
| 84 | MP0004233_abnormal_muscle_weight | 0.97575028 |
| 85 | MP0001835_abnormal_antigen_presentation | 0.96587378 |
| 86 | MP0003123_paternal_imprinting | 0.94544721 |
| 87 | MP0006054_spinal_hemorrhage | 0.94491483 |
| 88 | MP0000858_altered_metastatic_potential | 0.94295948 |
| 89 | MP0001730_embryonic_growth_arrest | 0.92353694 |
| 90 | MP0000350_abnormal_cell_proliferation | 0.92255512 |
| 91 | MP0004185_abnormal_adipocyte_glucose | 0.91706371 |
| 92 | MP0002019_abnormal_tumor_incidence | 0.91555056 |
| 93 | MP0004947_skin_inflammation | 0.90597323 |
| 94 | MP0003172_abnormal_lysosome_physiology | 0.90458268 |
| 95 | MP0003191_abnormal_cellular_cholesterol | 0.89208655 |
| 96 | MP0003252_abnormal_bile_duct | 0.87623126 |
| 97 | MP0009643_abnormal_urine_homeostasis | 0.87448534 |
| 98 | MP0003283_abnormal_digestive_organ | 0.86720000 |
| 99 | MP0005000_abnormal_immune_tolerance | 0.86349997 |
| 100 | MP0001851_eye_inflammation | 0.86317462 |
| 101 | MP0002166_altered_tumor_susceptibility | 0.85994444 |
| 102 | MP0001853_heart_inflammation | 0.84543532 |
| 103 | MP0005390_skeleton_phenotype | 0.84508553 |
| 104 | MP0009672_abnormal_birth_weight | 0.84363529 |
| 105 | MP0005671_abnormal_response_to | 0.84226411 |
| 106 | MP0000465_gastrointestinal_hemorrhage | 0.83374201 |
| 107 | MP0003806_abnormal_nucleotide_metabolis | 0.83373887 |
| 108 | MP0002254_reproductive_system_inflammat | 0.82724986 |
| 109 | MP0000003_abnormal_adipose_tissue | 0.82264843 |
| 110 | MP0002080_prenatal_lethality | 0.81874805 |
| 111 | MP0002118_abnormal_lipid_homeostasis | 0.81812667 |
| 112 | MP0005621_abnormal_cell_physiology | 0.81595943 |
| 113 | MP0005409_darkened_coat_color | 0.81458121 |
| 114 | MP0005375_adipose_tissue_phenotype | 0.81286634 |
| 115 | MP0003566_abnormal_cell_adhesion | 0.81170420 |
| 116 | MP0004197_abnormal_fetal_growth/weight/ | 0.80405761 |
| 117 | MP0003656_abnormal_erythrocyte_physiolo | 0.80387778 |
| 118 | MP0005025_abnormal_response_to | 0.80190485 |
| 119 | MP0002796_impaired_skin_barrier | 0.80013126 |
| 120 | MP0000313_abnormal_cell_death | 0.79579411 |
| 121 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78900750 |
| 122 | MP0008469_abnormal_protein_level | 0.78233318 |
| 123 | MP0005464_abnormal_platelet_physiology | 0.76768977 |
| 124 | MP0004883_abnormal_blood_vessel | 0.76168842 |
| 125 | MP0003638_abnormal_response/metabolism_ | 0.75756818 |
| 126 | MP0010307_abnormal_tumor_latency | 0.75137322 |
| 127 | MP0005666_abnormal_adipose_tissue | 0.74656039 |
| 128 | MP0001697_abnormal_embryo_size | 0.74235528 |
| 129 | MP0002088_abnormal_embryonic_growth/wei | 0.73737904 |
| 130 | MP0010329_abnormal_lipoprotein_level | 0.73480874 |
| 131 | MP0005023_abnormal_wound_healing | 0.72966494 |
| 132 | MP0001672_abnormal_embryogenesis/_devel | 0.72090186 |
| 133 | MP0005380_embryogenesis_phenotype | 0.72090186 |
| 134 | MP0002928_abnormal_bile_duct | 0.71969483 |
| 135 | MP0010234_abnormal_vibrissa_follicle | 0.71931497 |
| 136 | MP0001348_abnormal_lacrimal_gland | 0.71846533 |
| 137 | MP0009931_abnormal_skin_appearance | 0.71795024 |
| 138 | MP0003045_fibrosis | 0.68663957 |
| 139 | MP0005166_decreased_susceptibility_to | 0.68241306 |
| 140 | MP0000343_altered_response_to | 0.68005713 |
| 141 | MP0005164_abnormal_response_to | 0.67671755 |
| 142 | MP0001915_intracranial_hemorrhage | 0.67556101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.64932534 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.76854379 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.59884142 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.41800043 |
| 5 | Myositis (HP:0100614) | 4.31835969 |
| 6 | Orchitis (HP:0100796) | 4.12292362 |
| 7 | Decreased subcutaneous fat (HP:0001002) | 3.91007520 |
| 8 | Abnormality of subcutaneous fat tissue (HP:0001001) | 3.81729839 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.81037719 |
| 10 | Obstructive lung disease (HP:0006536) | 3.67829608 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 3.67829608 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 3.46833085 |
| 13 | Optic neuritis (HP:0100653) | 3.46833085 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 3.42633874 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.41499851 |
| 16 | Gingivitis (HP:0000230) | 3.29261066 |
| 17 | Increased IgE level (HP:0003212) | 3.18632107 |
| 18 | Steatorrhea (HP:0002570) | 3.13721312 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.08353493 |
| 20 | Stomatitis (HP:0010280) | 3.06388248 |
| 21 | Nasal polyposis (HP:0100582) | 2.96819104 |
| 22 | Meningitis (HP:0001287) | 2.90163940 |
| 23 | IgM deficiency (HP:0002850) | 2.88142115 |
| 24 | Fat malabsorption (HP:0002630) | 2.87354849 |
| 25 | Hypochromic anemia (HP:0001931) | 2.86995615 |
| 26 | Fatigue (HP:0012378) | 2.85815281 |
| 27 | Recurrent bronchitis (HP:0002837) | 2.83579838 |
| 28 | Abnormality of the nasal mucosa (HP:0000433) | 2.80192955 |
| 29 | Abnormality of the thoracic spine (HP:0100711) | 2.79756878 |
| 30 | Type I diabetes mellitus (HP:0100651) | 2.77847472 |
| 31 | Recurrent skin infections (HP:0001581) | 2.77058022 |
| 32 | Progressive muscle weakness (HP:0003323) | 2.76649734 |
| 33 | Thoracic kyphosis (HP:0002942) | 2.75377404 |
| 34 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.70795918 |
| 35 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.70795918 |
| 36 | Hypochromic microcytic anemia (HP:0004840) | 2.70306479 |
| 37 | Gastrointestinal inflammation (HP:0004386) | 2.68586172 |
| 38 | Urticaria (HP:0001025) | 2.65397368 |
| 39 | Short chin (HP:0000331) | 2.64951392 |
| 40 | Carpal bone hypoplasia (HP:0001498) | 2.63602898 |
| 41 | Broad face (HP:0000283) | 2.62889611 |
| 42 | Keratoconjunctivitis sicca (HP:0001097) | 2.57811163 |
| 43 | Late onset (HP:0003584) | 2.54066719 |
| 44 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.53188074 |
| 45 | Metaphyseal cupping (HP:0003021) | 2.50324653 |
| 46 | Gout (HP:0001997) | 2.48831550 |
| 47 | Multiple enchondromatosis (HP:0005701) | 2.40866718 |
| 48 | Inflammation of the large intestine (HP:0002037) | 2.40293981 |
| 49 | T lymphocytopenia (HP:0005403) | 2.39674940 |
| 50 | Joint stiffness (HP:0001387) | 2.38728874 |
| 51 | Encephalitis (HP:0002383) | 2.38440970 |
| 52 | Slow saccadic eye movements (HP:0000514) | 2.37759263 |
| 53 | Chest pain (HP:0100749) | 2.36774332 |
| 54 | Exocrine pancreatic insufficiency (HP:0001738) | 2.36150285 |
| 55 | Prolonged bleeding time (HP:0003010) | 2.34660556 |
| 56 | Abnormality of T cells (HP:0002843) | 2.33111653 |
| 57 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.32728674 |
| 58 | Flat acetabular roof (HP:0003180) | 2.32194361 |
| 59 | Increased connective tissue (HP:0009025) | 2.28757242 |
| 60 | Recurrent cutaneous fungal infections (HP:0011370) | 2.27152028 |
| 61 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.27152028 |
| 62 | Peritonitis (HP:0002586) | 2.27008942 |
| 63 | Basal cell carcinoma (HP:0002671) | 2.26078758 |
| 64 | Abnormality of T cell physiology (HP:0011840) | 2.26032565 |
| 65 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.26007224 |
| 66 | Increased serum ferritin (HP:0003281) | 2.25872925 |
| 67 | Vasculitis (HP:0002633) | 2.25050259 |
| 68 | Loss of speech (HP:0002371) | 2.24211345 |
| 69 | Dysostosis multiplex (HP:0000943) | 2.22553266 |
| 70 | Ketosis (HP:0001946) | 2.21201024 |
| 71 | Hyperacusis (HP:0010780) | 2.20478011 |
| 72 | Keratoconjunctivitis (HP:0001096) | 2.20006479 |
| 73 | Recurrent viral infections (HP:0004429) | 2.18611013 |
| 74 | Abnormality of the intrinsic pathway (HP:0010989) | 2.18498817 |
| 75 | Abnormal number of erythroid precursors (HP:0012131) | 2.17801377 |
| 76 | Abnormality of T cell number (HP:0011839) | 2.16921895 |
| 77 | Thrombocytosis (HP:0001894) | 2.16776106 |
| 78 | Cerebral aneurysm (HP:0004944) | 2.16564993 |
| 79 | Hypoplasia of the pons (HP:0012110) | 2.15018420 |
| 80 | Maternal diabetes (HP:0009800) | 2.13013482 |
| 81 | Myocardial infarction (HP:0001658) | 2.11655802 |
| 82 | Anorexia (HP:0002039) | 2.11142995 |
| 83 | Episodic fever (HP:0001954) | 2.10376036 |
| 84 | Mucopolysacchariduria (HP:0008155) | 2.09184332 |
| 85 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.09184332 |
| 86 | Arterial thrombosis (HP:0004420) | 2.08197817 |
| 87 | Hepatosplenomegaly (HP:0001433) | 2.07197533 |
| 88 | Hypoproteinemia (HP:0003075) | 2.06027910 |
| 89 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.06007052 |
| 90 | Hemorrhage of the eye (HP:0011885) | 2.05310054 |
| 91 | Abnormality of the fingertips (HP:0001211) | 2.04568949 |
| 92 | Obstructive sleep apnea (HP:0002870) | 2.03426182 |
| 93 | Ependymoma (HP:0002888) | 2.03258591 |
| 94 | Periodontitis (HP:0000704) | 2.02727042 |
| 95 | Abnormality of the peritoneum (HP:0002585) | 2.02696764 |
| 96 | Long palpebral fissure (HP:0000637) | 2.01979350 |
| 97 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.01466954 |
| 98 | Osteomyelitis (HP:0002754) | 2.01119378 |
| 99 | Premature skin wrinkling (HP:0100678) | 2.01051604 |
| 100 | Verrucae (HP:0200043) | 2.00833725 |
| 101 | Papilloma (HP:0012740) | 2.00833725 |
| 102 | Hypertensive crisis (HP:0100735) | 2.00463607 |
| 103 | Amyloidosis (HP:0011034) | 1.99344773 |
| 104 | Subacute progressive viral hepatitis (HP:0006572) | 1.98418750 |
| 105 | Epistaxis (HP:0000421) | 1.98058904 |
| 106 | Cortical dysplasia (HP:0002539) | 1.97409770 |
| 107 | Colitis (HP:0002583) | 1.96786809 |
| 108 | Reticulocytopenia (HP:0001896) | 1.95957188 |
| 109 | Deformed sella turcica (HP:0002681) | 1.95725307 |
| 110 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.93692364 |
| 111 | Severe short stature (HP:0003510) | 1.93270528 |
| 112 | Hand muscle atrophy (HP:0009130) | 1.90828607 |
| 113 | Ketoacidosis (HP:0001993) | 1.89793363 |
| 114 | Hypoglycemic coma (HP:0001325) | 1.88888746 |
| 115 | Hypertriglyceridemia (HP:0002155) | 1.88152640 |
| 116 | Ragged-red muscle fibers (HP:0003200) | 1.87823059 |
| 117 | Interstitial pulmonary disease (HP:0006530) | 1.87642349 |
| 118 | Hemoptysis (HP:0002105) | 1.87075430 |
| 119 | Lymphopenia (HP:0001888) | 1.86802350 |
| 120 | Polycythemia (HP:0001901) | 1.86267097 |
| 121 | Spontaneous hematomas (HP:0007420) | 1.85597100 |
| 122 | Distal lower limb amyotrophy (HP:0008944) | 1.85138781 |
| 123 | Sepsis (HP:0100806) | 1.84148076 |
| 124 | Microretrognathia (HP:0000308) | 1.83629151 |
| 125 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.83126791 |
| 126 | Rectal prolapse (HP:0002035) | 1.83010843 |
| 127 | Bronchitis (HP:0012387) | 1.82554359 |
| 128 | Abnormality of the common coagulation pathway (HP:0010990) | 1.80835869 |
| 129 | Abnormal vertebral ossification (HP:0100569) | 1.80773209 |
| 130 | Abnormality of iron homeostasis (HP:0011031) | 1.80581123 |
| 131 | Pathologic fracture (HP:0002756) | 1.80419590 |
| 132 | Petechiae (HP:0000967) | 1.80208863 |
| 133 | Selective tooth agenesis (HP:0001592) | 1.80125072 |
| 134 | Polygenic inheritance (HP:0010982) | 1.79601565 |
| 135 | Abnormality of the pons (HP:0007361) | 1.79485673 |
| 136 | Progressive external ophthalmoplegia (HP:0000590) | 1.79101285 |
| 137 | Abnormal platelet volume (HP:0011876) | 1.78897372 |
| 138 | Easy fatigability (HP:0003388) | 1.78556290 |
| 139 | High pitched voice (HP:0001620) | 1.77843425 |
| 140 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.77771135 |
| 141 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.77771135 |
| 142 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.77771135 |
| 143 | Viral hepatitis (HP:0006562) | 1.77571459 |
| 144 | Pancreatitis (HP:0001733) | 1.76525495 |
| 145 | Premature loss of primary teeth (HP:0006323) | 1.76370433 |
| 146 | Purpura (HP:0000979) | 1.76205017 |
| 147 | Skin ulcer (HP:0200042) | 1.75889989 |
| 148 | Gingival bleeding (HP:0000225) | 1.75844320 |
| 149 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.73784330 |
| 150 | Broad palm (HP:0001169) | 1.73354619 |
| 151 | Pallor (HP:0000980) | 1.71883850 |
| 152 | Pulmonary infiltrates (HP:0002113) | 1.71041198 |
| 153 | Hypermelanotic macule (HP:0001034) | 1.70261801 |
| 154 | Insulin resistance (HP:0000855) | 1.70152892 |
| 155 | Abnormality of the endocardium (HP:0004306) | 1.69848491 |
| 156 | Micronodular cirrhosis (HP:0001413) | 1.69753119 |
| 157 | Upper motor neuron abnormality (HP:0002127) | 1.69355757 |
| 158 | Thin bony cortex (HP:0002753) | 1.68471521 |
| 159 | Autoimmune thrombocytopenia (HP:0001973) | 1.68201128 |
| 160 | Disproportionate tall stature (HP:0001519) | 1.67835059 |
| 161 | Aseptic necrosis (HP:0010885) | 1.67573691 |
| 162 | Increased IgM level (HP:0003496) | 1.67375715 |
| 163 | Pustule (HP:0200039) | 1.67247182 |
| 164 | Esophageal varix (HP:0002040) | 1.66908745 |
| 165 | Cellulitis (HP:0100658) | 1.66807370 |
| 166 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.66738495 |
| 167 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.65999165 |
| 168 | Microcytic anemia (HP:0001935) | 1.65600603 |
| 169 | Increased cerebral lipofuscin (HP:0011813) | 1.64835632 |
| 170 | Chronic otitis media (HP:0000389) | 1.63486343 |
| 171 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.63484136 |
| 172 | Mitral valve prolapse (HP:0001634) | 1.62488297 |
| 173 | Gastrointestinal stroma tumor (HP:0100723) | 1.61870028 |
| 174 | Abnormal platelet function (HP:0011869) | 1.59924606 |
| 175 | Impaired platelet aggregation (HP:0003540) | 1.59924606 |
| 176 | Macrocytic anemia (HP:0001972) | 1.59222062 |
| 177 | Recurrent fungal infections (HP:0002841) | 1.59031529 |
| 178 | Increased density of long bones (HP:0006392) | 1.58218309 |
| 179 | Asymmetric septal hypertrophy (HP:0001670) | 1.57778032 |
| 180 | Hypoglycemic seizures (HP:0002173) | 1.57107474 |
| 181 | Emphysema (HP:0002097) | 1.57082085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.47440163 |
| 2 | TRIB3 | 4.34240954 |
| 3 | PKN2 | 3.91336770 |
| 4 | BCKDK | 3.89968873 |
| 5 | EEF2K | 3.53377792 |
| 6 | MAP3K10 | 3.29238242 |
| 7 | RIPK4 | 3.25414566 |
| 8 | MAP4K1 | 3.14545570 |
| 9 | SMG1 | 2.98288116 |
| 10 | PRPF4B | 2.66951803 |
| 11 | ZAP70 | 2.31019791 |
| 12 | TAOK1 | 2.19323860 |
| 13 | TNK2 | 2.03875442 |
| 14 | MAP3K3 | 1.92910507 |
| 15 | NME2 | 1.89201289 |
| 16 | EPHB1 | 1.87111814 |
| 17 | MAP2K2 | 1.76937743 |
| 18 | STK10 | 1.76836540 |
| 19 | LRRK2 | 1.54475099 |
| 20 | PTK6 | 1.53079484 |
| 21 | ICK | 1.49964729 |
| 22 | TYK2 | 1.49253633 |
| 23 | TAOK2 | 1.49155056 |
| 24 | FLT3 | 1.46161873 |
| 25 | NEK2 | 1.45273487 |
| 26 | PASK | 1.42801176 |
| 27 | GRK6 | 1.41729316 |
| 28 | KSR2 | 1.39505088 |
| 29 | MARK2 | 1.39364754 |
| 30 | CDK4 | 1.38985784 |
| 31 | JAK3 | 1.35999038 |
| 32 | FGR | 1.31442819 |
| 33 | SIK3 | 1.31415767 |
| 34 | RPS6KB2 | 1.31259283 |
| 35 | MAP3K1 | 1.29635926 |
| 36 | FES | 1.29154579 |
| 37 | CDK12 | 1.27321712 |
| 38 | IRAK2 | 1.24173280 |
| 39 | FGFR4 | 1.23733544 |
| 40 | MAP3K14 | 1.23286720 |
| 41 | SIK1 | 1.22185280 |
| 42 | TTN | 1.18767254 |
| 43 | MTOR | 1.18405419 |
| 44 | MAPKAPK3 | 1.17325518 |
| 45 | IRAK3 | 1.15260407 |
| 46 | MAP3K8 | 1.12313743 |
| 47 | PAK2 | 1.11871060 |
| 48 | PAK4 | 1.10554127 |
| 49 | MAP3K13 | 1.09855942 |
| 50 | BLK | 1.09132404 |
| 51 | SCYL2 | 1.08293126 |
| 52 | BTK | 1.07370419 |
| 53 | TBK1 | 1.03786319 |
| 54 | TGFBR2 | 1.02339422 |
| 55 | RPS6KA4 | 0.99875066 |
| 56 | MAP2K3 | 0.90817110 |
| 57 | CDC42BPA | 0.90174653 |
| 58 | PIM1 | 0.89697688 |
| 59 | PDPK1 | 0.88073076 |
| 60 | KDR | 0.87652099 |
| 61 | CSF1R | 0.86852981 |
| 62 | TAOK3 | 0.86334189 |
| 63 | CDC7 | 0.85856320 |
| 64 | EIF2AK3 | 0.84970786 |
| 65 | MAP3K6 | 0.83511087 |
| 66 | DYRK1B | 0.78873153 |
| 67 | RPS6KC1 | 0.77571714 |
| 68 | RPS6KL1 | 0.77571714 |
| 69 | SIK2 | 0.76597041 |
| 70 | WEE1 | 0.74070786 |
| 71 | MAPK11 | 0.73317689 |
| 72 | IRAK1 | 0.71413510 |
| 73 | CAMK1D | 0.70199496 |
| 74 | BUB1 | 0.69947335 |
| 75 | MATK | 0.65556477 |
| 76 | DYRK3 | 0.65517179 |
| 77 | JAK1 | 0.65059949 |
| 78 | JAK2 | 0.63114171 |
| 79 | ITK | 0.62806446 |
| 80 | STK4 | 0.62098875 |
| 81 | CSK | 0.61698180 |
| 82 | TESK1 | 0.60879464 |
| 83 | CDK6 | 0.60270843 |
| 84 | IRAK4 | 0.59146770 |
| 85 | RPS6KA6 | 0.58859025 |
| 86 | RPS6KA2 | 0.58606661 |
| 87 | SYK | 0.58271453 |
| 88 | ATR | 0.58029087 |
| 89 | KIT | 0.57006697 |
| 90 | MAP3K2 | 0.56239235 |
| 91 | RAF1 | 0.54351821 |
| 92 | MST1R | 0.54094068 |
| 93 | TTK | 0.53074903 |
| 94 | MAP3K7 | 0.52968408 |
| 95 | STK38 | 0.52248550 |
| 96 | LCK | 0.51913157 |
| 97 | HCK | 0.51694053 |
| 98 | MELK | 0.51588128 |
| 99 | RPS6KA1 | 0.51526615 |
| 100 | ALK | 0.50977675 |
| 101 | PRKG2 | 0.50725242 |
| 102 | IKBKB | 0.50395180 |
| 103 | RIPK1 | 0.50252204 |
| 104 | MARK3 | 0.49572939 |
| 105 | PDGFRA | 0.49186124 |
| 106 | MAPK15 | 0.48985919 |
| 107 | CDK9 | 0.48516659 |
| 108 | CDK7 | 0.47913770 |
| 109 | YES1 | 0.47110050 |
| 110 | ILK | 0.46542724 |
| 111 | TGFBR1 | 0.45718318 |
| 112 | PDK1 | 0.45444410 |
| 113 | TLK1 | 0.44301254 |
| 114 | AURKB | 0.43657107 |
| 115 | TESK2 | 0.43605000 |
| 116 | PRKD2 | 0.43209098 |
| 117 | PDGFRB | 0.42502026 |
| 118 | BMX | 0.42342126 |
| 119 | TEC | 0.42332272 |
| 120 | PDK3 | 0.42314609 |
| 121 | PDK4 | 0.42314609 |
| 122 | MAPK12 | 0.41744142 |
| 123 | EPHA2 | 0.40980069 |
| 124 | PRKCH | 0.40786712 |
| 125 | SGK3 | 0.40230111 |
| 126 | MAPKAPK2 | 0.39605840 |
| 127 | TSSK6 | 0.39331120 |
| 128 | CLK1 | 0.38447490 |
| 129 | CAMK1G | 0.37838923 |
| 130 | CHEK1 | 0.37741928 |
| 131 | HIPK2 | 0.37611529 |
| 132 | MAP3K11 | 0.37188438 |
| 133 | IKBKE | 0.34734603 |
| 134 | BRAF | 0.34474715 |
| 135 | CDK2 | 0.33344259 |
| 136 | MAP2K6 | 0.33328549 |
| 137 | RET | 0.32635317 |
| 138 | LYN | 0.32100224 |
| 139 | FYN | 0.31612655 |
| 140 | STK3 | 0.31432695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pancreatic secretion_Homo sapiens_hsa04972 | 4.42188829 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.73934345 |
| 3 | Protein digestion and absorption_Homo sapiens_hsa04974 | 3.22733407 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.48121265 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.40292035 |
| 6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.31940985 |
| 7 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.24800144 |
| 8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.03149022 |
| 9 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.99223512 |
| 10 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.99195015 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.99089952 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.86873831 |
| 13 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.83471929 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 1.82012907 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.75818172 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.74456374 |
| 17 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.73525300 |
| 18 | Ribosome_Homo sapiens_hsa03010 | 1.73179865 |
| 19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.72070478 |
| 20 | Mismatch repair_Homo sapiens_hsa03430 | 1.68484031 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.68210552 |
| 22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.54766708 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.53246817 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.47130853 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.41546516 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.38980548 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36756477 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.35636824 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32546513 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30082291 |
| 31 | Sulfur relay system_Homo sapiens_hsa04122 | 1.27107504 |
| 32 | Lysine degradation_Homo sapiens_hsa00310 | 1.26008964 |
| 33 | Hepatitis C_Homo sapiens_hsa05160 | 1.25006000 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.23808130 |
| 35 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.22921555 |
| 36 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.18181433 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.16841005 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.14257044 |
| 39 | Spliceosome_Homo sapiens_hsa03040 | 1.13672678 |
| 40 | RNA transport_Homo sapiens_hsa03013 | 1.13342578 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.11881938 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.11548977 |
| 43 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.05460417 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 1.05213604 |
| 45 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.02676506 |
| 46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.02459679 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.00260891 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99472019 |
| 49 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.99140216 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98183210 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98066806 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.97729032 |
| 53 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.97068189 |
| 54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.96954535 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 0.93711279 |
| 56 | Protein export_Homo sapiens_hsa03060 | 0.93028103 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92084977 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.91779003 |
| 59 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.91326939 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.91031940 |
| 61 | Endocytosis_Homo sapiens_hsa04144 | 0.91012606 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90777919 |
| 63 | Allograft rejection_Homo sapiens_hsa05330 | 0.90579784 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.90506825 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88456700 |
| 66 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.87298498 |
| 67 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.86699971 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86111931 |
| 69 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86068715 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.85998403 |
| 71 | Measles_Homo sapiens_hsa05162 | 0.85724987 |
| 72 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.85513776 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84970245 |
| 74 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.82916919 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82511127 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81863361 |
| 77 | Prostate cancer_Homo sapiens_hsa05215 | 0.80827098 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78982908 |
| 79 | Pertussis_Homo sapiens_hsa05133 | 0.78916790 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78881562 |
| 81 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.78606705 |
| 82 | Cell cycle_Homo sapiens_hsa04110 | 0.78563539 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78450192 |
| 84 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.77971385 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.77967208 |
| 86 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.77791918 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77664527 |
| 88 | Legionellosis_Homo sapiens_hsa05134 | 0.77604389 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77364477 |
| 90 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.77144225 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.75885786 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74853029 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74085808 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73519343 |
| 95 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73422331 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.72801173 |
| 97 | Homologous recombination_Homo sapiens_hsa03440 | 0.72642432 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72252977 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.72170996 |
| 100 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71584394 |
| 101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70844137 |
| 102 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.70671218 |
| 103 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.70668112 |
| 104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69851087 |
| 105 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.69777181 |
| 106 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.69566028 |
| 107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69436276 |
| 108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69431272 |
| 109 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69106708 |
| 110 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68387453 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | 0.68198585 |
| 112 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.68136980 |
| 113 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67312930 |
| 114 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67282335 |
| 115 | Leishmaniasis_Homo sapiens_hsa05140 | 0.67240089 |
| 116 | Apoptosis_Homo sapiens_hsa04210 | 0.66230307 |
| 117 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66012171 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.65874910 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.65287345 |
| 120 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.65223745 |
| 121 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63192984 |
| 122 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61843888 |
| 123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.61761856 |
| 124 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59440741 |
| 125 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.57054909 |
| 126 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56577661 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56378983 |
| 128 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.56270453 |
| 129 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53667414 |
| 130 | Viral myocarditis_Homo sapiens_hsa05416 | 0.52871134 |
| 131 | Hepatitis B_Homo sapiens_hsa05161 | 0.52377646 |
| 132 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51714729 |
| 133 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51252555 |
| 134 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50840144 |
| 135 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50616071 |
| 136 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50304681 |
| 137 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49968917 |
| 138 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.49779381 |
| 139 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48820671 |
| 140 | Bladder cancer_Homo sapiens_hsa05219 | 0.48697150 |
| 141 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48128593 |
| 142 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47366885 |
| 143 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46016176 |
| 144 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44301277 |
| 145 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44183774 |
| 146 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43728091 |
| 147 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40091078 |
| 148 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.38796583 |
| 149 | Thyroid cancer_Homo sapiens_hsa05216 | 0.38331925 |
| 150 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37598847 |
| 151 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.35898077 |
| 152 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.35040158 |
| 153 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34816816 |
| 154 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.34225620 |

